| __timestamp | HUTCHMED (China) Limited | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 19764000 | 519428000 |
| Thursday, January 1, 2015 | 67426000 | 906794000 |
| Friday, January 1, 2016 | 59752000 | 1491717000 |
| Sunday, January 1, 2017 | 65383000 | 2213533000 |
| Monday, January 1, 2018 | 70165000 | 2638058000 |
| Tuesday, January 1, 2019 | 44738000 | 3615063000 |
| Wednesday, January 1, 2020 | 39457000 | 5469383000 |
| Friday, January 1, 2021 | 97894000 | 6670200000 |
| Saturday, January 1, 2022 | 115306000 | 7850400000 |
| Sunday, January 1, 2023 | 453552000 | 8607000000 |
| Monday, January 1, 2024 | 9489600000 |
Unlocking the unknown
In the dynamic world of biotechnology, financial performance often mirrors innovation and market adaptation. Over the past decade, Vertex Pharmaceuticals Incorporated and HUTCHMED (China) Limited have showcased contrasting trajectories in gross profit. Vertex, a leader in cystic fibrosis treatments, has seen its gross profit skyrocket by over 1,500% from 2014 to 2023, reflecting its robust pipeline and market dominance. In contrast, HUTCHMED, focusing on oncology and immunology, experienced a more modest growth of approximately 2,200% in the same period, indicating its strategic expansion in the Chinese market. Notably, 2023 marked a significant leap for HUTCHMED, with a gross profit surge of nearly 300% compared to the previous year. This comparison not only highlights the diverse strategies of these companies but also underscores the potential of emerging markets in shaping the future of biotechnology.
Sanofi vs Vertex Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs HUTCHMED (China) Limited
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Takeda Pharmaceutical Company Limited Trends
Key Insights on Gross Profit: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Key Insights on Gross Profit: Vertex Pharmaceuticals Incorporated vs Perrigo Company plc
Gross Profit Analysis: Comparing Vertex Pharmaceuticals Incorporated and Arrowhead Pharmaceuticals, Inc.
Key Insights on Gross Profit: Zoetis Inc. vs HUTCHMED (China) Limited
Gross Profit Trends Compared: Regeneron Pharmaceuticals, Inc. vs HUTCHMED (China) Limited
Jazz Pharmaceuticals plc and HUTCHMED (China) Limited: A Detailed Gross Profit Analysis
Grifols, S.A. vs HUTCHMED (China) Limited: A Gross Profit Performance Breakdown
Gross Profit Comparison: Perrigo Company plc and HUTCHMED (China) Limited Trends
Gross Profit Comparison: HUTCHMED (China) Limited and BioCryst Pharmaceuticals, Inc. Trends